@ARTICLE{
author={Dingemanse Jasper,Otasevic Petar M,Shakeri-Nejad K,Klainman E,Putnikovic Biljana,Kracker H,Mueller MS,Zimlichman R},
year={2015},
title={Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension},
journal={JOURNAL OF HUMAN HYPERTENSION},
volume={29},
number={4},
pages={229-235},
document_type={Article},
} 

@ARTICLE{
author={Dingemanse Jasper,Otasevic Petar M,Shakeri-Nejad K,Klainman E,Putnikovic Biljana,Kracker H,Mueller MS,Zimlichman R},
year={2013},
title={Efficacy and Safety of Act-280778, a Dual L- and T-Type Calcium Channel Blocker, in Patients with Mild-To-Moderate Essential Hypertension: Results from a Phase 2a, Randomized, Double-Blind, Placebo- and Active-Controlled Trial (Reduce-1)},
journal={CLINICAL PHARMACOLOGY & THERAPEUTICS},
volume={93},
number={},
pages={S33-S33},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Lebrec Didier,Bosch Jaime,Jalan Rajiv,Dudley Francis J,Jesic Rada S,Moreau Richard,Carlos Garcia-Pagan Juan,Mookerjee Rajeshwar P,Chiossi Eleonora,Van Giersbergen Paul LM,Kusic-Pajic Andjela,Dingemanse Jasper},
year={2012},
title={Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis},
journal={EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY},
volume={68},
number={5},
pages={533-541},
document_type={Article},
} 

@ARTICLE{
author={Lebrec Didier,Bosch Jaime,Jalan Rajiv,Dudley Francis J,Jesic Rada S,Garcia-Pagan JC,Mookerjee Rajeshwar P,Moreau Richard,van Giersbergen PLM,Kusic-Pajic Andjela,Dingemanse Jasper},
year={2010},
title={Hemodynamic Effects of Tezosentan, a Dual Endothelin Receptor Antagonist, in Patients with Cirrhosis},
journal={JOURNAL OF HEPATOLOGY},
volume={52},
number={},
pages={S210-S210},
document_type={Meeting Abstract},
}